+467.0%
MRNA vs BIIB
+51.4%
+415.7%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | BIIB | Excess | Alpha |
|---|---|---|---|---|
| 1D | +5.4% | +0.8% | +4.6% | +4.5% |
| 7D | -1.1% | -1.7% | +0.6% | +0.8% |
| 30D | +126.1% | +4.0% | +122.2% | +127.7% |
| 3M | +190.0% | +8.6% | +181.4% | +183.9% |
| 6M | +157.2% | +14.0% | +143.2% | +144.3% |
| YTD | +388.2% | +23.4% | +364.8% | +328.9% |
| 1Y | +467.0% | +45.9% | +421.1% | +336.4% |
| All | +467.0% | +51.4% | +415.7% | +336.4% |
Cumulative growth
Daily Returns
Daily percentage return beside BIIB.
Daily Out/Under-Performance
Portfolio return minus BIIB return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × BIIB return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded BIIB wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling